12/11/2024
7:33 AM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/03/2024
7:32 AM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/29/2024
3:30 PM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/20/2024
7:02 AM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024
7:01 AM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/31/2024
3:05 PM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/30/2024
7:01 AM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
10/15/2024
5:03 AM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K/A | |
09/26/2024
7:32 AM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/24/2024
7:33 AM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/11/2024
7:30 AM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/23/2024
7:02 AM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/24/2024
7:02 AM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024
7:04 AM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/17/2024
7:03 AM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/14/2024
3:30 PM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/03/2024
7:05 AM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024
7:13 AM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024
7:01 AM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2024
7:02 AM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/16/2024
7:00 AM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2024
7:13 AM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/29/2024
3:30 PM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/07/2024
7:02 AM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/22/2024
7:00 AM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/17/2024
7:02 AM | Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
